More Arthritus Information and Resources:

Arthritis / Rheumatology News From Medical News Today
Latest Arthritis / Rheumatology News From Medical News Today.

• Better Management More Important Than New Drugs For Arthritis
  Posted on 29 Nov 2008 at 2:00am
  Although there has been an increase in the number of new arthritis treatments in recent years, the best results will come from more effective use of the drugs we have. Research published in BioMed Central's open access journal Arthritis Research and Therapy investigates the effectiveness of available arthritis drugs and concludes that better management is the most important factor.
  
• Key US Patent Granted On Antibodies Against GM-CSF To Treat Inflammatory Diso...
  Posted on 25 Nov 2008 at 7:00am
  MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and the University of Melbourne announced today that the U.S. Patent & Trademark Office (USPTO) has confirmed that it will issue U.S. Patent No. 7,455,836, covering key uses of antibodies against GM-CSF. The patent stems from a provisional patent application filed in the USPTO in 2000 by the University of Melbourne.
  
• Arthritis Advisory Committee Recommends FDA Approval Of Febuxostat For The Tr...
  Posted on 25 Nov 2008 at 6:00am
  Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced today that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended that the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout. The vote was 12 to zero in favor of approval, with one panel member abstaining.
  
• NICE Admits Previous Guidance Around Sequential Use Of Anti-TNF Therapies In ...
  Posted on 24 Nov 2008 at 9:00am
  The National Institute of Health and Clinical Excellence (NICE) has today published findings of its appeal panel around the use of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis (RA) after failure of a previous TNF-α inhibitor (sequential use), deciding their previous guidance had been 'unfair' and 'perverse'1.
  
• RoActemra Receives Positive Opinion In Europe For The Treatment Of Rheumatoid...
  Posted on 22 Nov 2008 at 2:00am
  Roche announced that the European Committee on Human Medicinal Products (CHMP) has given a positive recommendation for RoActemra (tocilizumab, known as Actemra outside of the EU), in combination with methotrexate (MTX), for the treatment of adult patients with moderate to severe rheumatoid arthri